Search
for

    Sort by

    Research 871–900 of 1000+

    1. Acute liver damage due to <i>Serenoa repens</i>: a case report British Journal of Clinical Pharmacology · 2010 · 35 citations
    2. Maximum Efficacy of Finasteride Is Obtained within 6 Months and Maintained over 6 Years European Urology · 1998 · 34 citations
    3. Finasteride-its impact on sexual function and prostate cancer Journal of Cutaneous and Aesthetic Surgery · 2009 · 33 citations
    4. Patients with a large prostate show a higher prevalence of androgenetic alopecia Archives of Dermatological Research · 2004 · 33 citations
    5. Review of Scalp Alopecia due to a Clinically Unapparent or Minimally Apparent Neoplasm (SACUMAN) Acta dermato-venereologica · 2006 · 32 citations
    6. The Effect of 5 -Reductase Inhibitors on Erectile Function International Journal of Andrology · 2008 · 31 citations
    7. Clinical relevance of testosterone and dihydrotestosterone metabolism in women ˜The œAmerican journal of medicine · 1995 · 31 citations
    8. Post-finasteride syndrome: a surmountable challenge for clinicians Fertility and Sterility · 2020 · 30 citations
    9. Improvement in androgenetic alopecia in 53-76-year-old men using oral finasteride International Journal of Dermatology · 1999 · 30 citations
    10. Oral ivermectin in the treatment of scabies International Journal of Dermatology · 1999 · 30 citations
    11. Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study BMJ. British medical journal · 2019 · 29 citations
    12. Finasteride-associated cataract and intraoperative floppy-iris syndrome Journal of Cataract and Refractive Surgery · 2011 · 29 citations
    13. In Vivo Time-Dependent Inhibition of Human Steroid 5a-Reductase by Finasteride Journal of Pharmaceutical Sciences · 1996 · 29 citations
    14. Does a male polycystic ovarian syndrome equivalent exist? Journal of Endocrinological Investigation · 2017 · 28 citations
    15. Long-term use of 5α-reductase inhibitors and the risk of male breast cancer Cancer Causes & Control · 2014 · 28 citations
    16. Ejaculatory dysfunction in the treatment of lower urinary tract symptoms Translational Andrology and Urology · 2016 · 26 citations
    17. 5α-Reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives International Journal of Biological Macromolecules · 2011 · 26 citations
    18. The placebo effect and randomized trials: analysis of conventional medicine Urologic clinics of North America · 2002 · 26 citations
    19. History as a Tool in Identifying “New” Old Drugs Advances in experimental medicine and biology · 2002 · 26 citations
    20. 13C-NMR study of 4-azasteroids in solution and solid state Steroids · 2002 · 25 citations
    21. Assessing finasteride-associated sexual dysfunction using the FAERS database Journal of The European Academy of Dermatology and Venereology · 2017 · 24 citations
    22. Persistent Sexual and Nonsexual Adverse Effects of Finasteride in Younger Men Sexual medicine reviews · 2013 · 24 citations
    23. Eyelash trichomegaly: review of congenital, acquired, and drug‐associated etiologies for elongation of the eyelashes International Journal of Dermatology · 2012 · 24 citations
    24. Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats Andrologia · 2011 · 24 citations
    25. The effects of lovastatin on conventional medical treatment of lower urinary tract symptoms with finasteride International Braz J Urol · 2008 · 24 citations
    26. Dihydrotestosteron und die Rolle der 5α-Reduktasehemmer bei der benignen Prostatahyperplasie Der Urologe · 2002 · 24 citations
    27. Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride International Journal of Pharmaceutics · 2021 · 23 citations
    28. Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study Clinical Therapeutics · 1999 · 23 citations
    29. Finasteride: The First 5α-Reductase Inhibitor Pharmacotherapy · 1993 · 23 citations
    30. THE PREVALENCE OF SKIN DISEASE IN THE GERIATRIC AGE GROUP Australasian Journal of Dermatology · 1987 · 23 citations